JSJanusz Springer

Janusz Springer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janusz Springer has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Presentations of Pseudomonas aeruginosa Infection in Children with Leukaemia Treated with Chemotherapy—A Series of 5 Cases with Discussion

    by Maciej Niedźwiecki, Janusz Springer, Piotr Czauderna, Mieszko Czapliński, Ninela Irga-Jaworska, Monika Lejman

    Background: Ecthyma gangrenosum (EG) associated with Pseudomonas aeruginosa can be life-threatening in immunocompromised patients with haematological malignancies. Severe neutropenia and antimicrobial resistance complicate treatment, while the roles of surgery and supportive therapies remain uncertain. Methods: We retrospectively reviewed five paediatric patients with leukaemia who developed life-threatening P. aeruginosa infections during chemotherapy. Cases were identified through a tertiary paediatric oncology centre’s clinical registry and verified using archived medical records. Clinical, microbiological, therapeutic, and outcome data, including surgical interventions, supportive therapies, and chemotherapy interruptions, were analysed. Results: All five patients developed severe infections during chemotherapy. EG affected the perineal or genital region in several cases, including two cases of Fournier’s gangrene. Four patients underwent surgical excision or debridement; surgery was not feasible in one because of critical deterioration. All received antimicrobials, with regimens adjusted according to microbiological findings and susceptibility profiles. Supportive treatments included granulocyte colony-stimulating factor, immunoglobulins, and granulocyte transfusions. Two patients survived into adulthood, including one who remained in remission after haematopoietic stem cell transplantation; three died, one from infection-associated multiorgan failure before surgery, one following leukaemia relapse, and one from post-transplant complications. Infection and its treatment substantially delayed or modified chemotherapy. Conclusions: EG associated with P. aeruginosa during paediatric leukaemia treatment can cause death and disrupt anticancer therapy. Early multidisciplinary assessment, appropriate antimicrobial treatment, and timely surgical management of necrotic tissue should be considered when feasible. Immunomodulatory interventions and discharge between chemotherapy cycles may benefit selected patients, but their efficacy cannot be established from this small retrospective series. Further multicentre studies are needed to clarify optimal management.

  • Open Access

    Long-Term Sequelae in Patients Treated for Recurrent CNS Relapses of Pediatric B-Cell Acute Lymphoblastic Leukemia: 20-Year Follow-Up, Neurological Consequences, and Survivorship Burden—A Case Report and Literature Review

    by Maciej Niedźwiecki, Monika Lejman, Mieszko Czapliński, Janusz Springer, Anna Synakiewicz, Eliza Wasilewska

    Central nervous system (CNS) relapse remains a major cause of treatment failure in pediatric acute lymphoblastic leukemia (ALL). Repeated isolated CNS relapse is particularly rare and associated with poor prognosis, while optimal therapeutic strategies remain insufficiently defined. Intensified CNS-directed therapy may improve disease control but is also associated with substantial long-term neurotoxicity and survivorship burden. We present the case of a boy with favorable-risk B-cell ALL who developed two isolated CNS relapses despite a good initial response to frontline therapy and absence of classical CNS relapse risk factors. The second relapse was associated with extensive meningeal involvement and optic nerve infiltration. The patient underwent intensive multimodal CNS-directed therapy, including repeated intrathecal chemotherapy, liposomal cytarabine administered according to the IntReALL 2010 protocol, cranial irradiation, and allogeneic hematopoietic stem cell transplantation (alloHSCT) from a matched sibling donor. Durable long-term remission was achieved despite the extremely unfavorable prognosis that is associated with a second isolated CNS relapse. A twenty-year follow-up extending into early adulthood revealed substantial late complications, including epilepsy, transient ischemic attack, optic nerve injury, endocrinopathies, obesity, secondary thyroid malignancy, neurocognitive difficulties, and depression requiring long-term psychiatric and psychological support. The present case illustrates the complex balance between effective CNS disease control and cumulative treatment-related neurotoxicity in pediatric ALL survivors. It also highlights the cumulative CNS injury and long-term survivorship burden that is associated with repeated CNS relapse and multimodal CNS-directed therapy.


  • Open Access

    Ecthyma Gangrenosum as Clinical Presentation of Pseudomonas aeruginosa Infection in Children with Leukaemia - A Case Series

    by Maciej Niedźwiecki, Janusz Springer, Piotr Czauderna, Mieszko Czapliński, Ninela Irga-Jaworska

    Ecthyma gangrenosum (EG) is one of the manifestations of skin infections affecting immunocompromised patients. Pseudomonas aeruginosa is an important etiologic factor. The cutaneous localization of EG lesions usually is the consequence of bacteraemia. Neutropenia is the main risk factor for EG in patients with haematological malignancies. In this paper we present four cases of EG in children with acute leukaemia, who underwent chemotherapy and were treated with broad spectrum antibiotics, immunoglobulins and G-CSF. Granulocyte mass was given in three cases and one patient underwent hyperbaric treatment. All of those methods were insufficient and the patients did not improve until wide surgical excision of necrotic changes was done. The outcomes of severe EG were poor. Only in one case the patient recovered from infection and the leukaemia. One patient died of P. aeruginosa sepsis and septic shock. Two were healed of infection, but later died of leukaemia relapses. We conclude that EG leads to prolonged delays in haematological treatment and EG management should also include early surgical intervention to remove the necrotic lesions and to incise the regions of inflammatory changes.

  • Open Access

    Successful Treatment of Catastrophic Antiphospholipid Syndrome with Mycophenolate Mofetil in a Teenager Without Underlying Disease

    by Maciej Niedźwiecki, Janusz Springer, Magdalena Drozyńska-Duklas, Piotr Czarniak, Mieszko Czapliński

    Catastrophic antiphospholipid syndrome (CAPS) is a severe form of the antiphospholipid syndrome, a rare autoimmune disease characterized by the presence of antiphospholipid antibodies (APAs) directed against endothelial and plasma proteins in association with recurrent venous and/or arterial thromboembolic events and/or foetal loss. CAPS is marked by small vessel thrombosis, multiorgan failure and a mortality rate of up to 50%. The currently preferred treatment regimen for CAPS includes: anticoagulants, glucocorticosteroids, plasmapheresis with or without intravenous immunoglobulins. Our case of a paediatric CAPS patient is unusual for two reasons: 1) the patient did not suffer from SLE or any other risk factor correlated with increased possibility of thrombosis or CAPS and 2) it is probably the first published case demonstrating successful a remission of CAPS with the immunosuppressant mycophenolate mofetil (MMF) and anti-coagulants. Thus, our case highlights the need for further clinical trials of the effectiveness of new immunosuppressants in the treatment of CAPS and APS.

  • Open Access

    Intrathecal Liposomal Cytarabine as Bridge Therapy to Allogenic Hematopoietic Stem Cell Transplantation in Second Isolated CNS Relapse of Paediatric B-Cell Acute Lymphoblastic Leukaemia: 15-Year Follow-Up, Neurological Sequelae, and Survivorship Burden - A Case Report and Literature Review

    by Maciej Niedźwiecki, Monika Lejman, Mieszko Czaplinski, Janusz Springer, Anna Synakiewicz, Eliza Wasilewska

    Central nervous system (CNS) relapse remains a major cause of treatment failure in paediatric acute lymphoblastic leukaemia (ALL). Repeated isolated CNS relapse is particularly rare and associated with poor prognosis, while optimal therapeutic strategies remain insufficiently defined. Intensified CNS-directed therapy may improve disease control but is also associated with substantial long-term neurotoxicity and survivorship burden. We present the case of a boy with favourable-risk B-cell ALL who developed two isolated CNS relapses despite good initial response to frontline therapy and absence of classical CNS relapse risk factors. The second relapse was associated with extensive meningeal involvement and optic nerve infiltration. The patient underwent intensive multimodal CNS-directed therapy including repeated intrathecal chemotherapy, liposomal cytarabine administered according to the IntReALL 2010 protocol, cranial irradiation, and allogeneic hematopoietic stem cell transplantation (alloHSCT) from a matched sibling donor. Durable long-term remission was achieved despite the extremely unfavourable prognosis associated with second isolated CNS relapse. Fifteen-year follow-up extending into early adulthood revealed substantial late complications, including epilepsy, transient ischemic attack, optic nerve injury, endocrinopathies, obesity, secondary thyroid malignancy, neurocognitive difficulties, and depression requiring long-term psychiatric and psychological support. The present case illustrates the complex balance between effective CNS disease control and cumulative treatment-related neurotoxicity in paediatric ALL survivors. It also highlights the cumulative CNS injury and long-term survivorship burden associated with repeated CNS relapse and multimodal CNS-directed therapy.

  • Open Access

    Severe Anemia as a Rare Complication of Traumatic Scalp Arteriovenous Fistula: A Case Report

    by Szymon R. Mielczarek, Jacek Kleszczyński, Katarzyna Sznajder, Janusz Springer

    Severe Anemia as a Rare Complication of Traumatic Scalp Arteriovenous Fistula: A Case Report - Article abstract #951547

  • Corrigendum to “Effectiveness of antazoline versus amiodarone, flecainide and propafenone in restoring sinus rhythm at the emergency department” [Adv. Med. Sci (2024 Sep) 69(2) 248–255]

    by Janusz Springer, Michalina Pejska, Wojciech Homenda, Tomasz Zdrojewski, Ludmiła Daniłowicz-Szymanowicz, Dariusz Kozłowski

  • Open Access

    Polish-language adaptation of the Oxford Depression Questionnaire (ODQ)

    by Wiesław Jerzy Cubała, Katarzyna Alicja Milska-Musa, Jerzy Landowski, Mariusz Stanisław Wiglusz, Adam Włodarczyk, Joanna Szarmach, Janusz Springer, Jakub Słupski

    Emotional disorders associated with antidepressant treatment (e.g. anhedonia and emotional blunting) are significant clinical and research concerns which influence treatment effectiveness and patients’ quality of life. Nearly one-third of patients treated with antidepressants report experiencing apathy, with approximately 8% describing it as moderate to severe. Similarly, about 40% report a loss of motivation, with 12% characterising this symptom as moderate or severe. The Oxford Depression Questionnaire (ODQ) is a standardised tool developed to assess the severity, differentiation, and duration of emotional disorders related to the use of selective serotonin reuptake inhibitors (SSRI) antidepressants, distinguishing them from core depressive symptoms, such as anhedonia. The ODQ consists of 26 items divided into three sections, assessing weekly emotional experiences, changes compared to before the illness, and the influence of antidepressants on emotional functioning. This study presents the Polish-language adaptation of the ODQ, deemed appropriate for both clinical and research purposes, providing a robust tool for assessing SSRI-induced emotional changes and aiding in differential diagnosis and treatment planning.


  • The #BlueWhaleChallenge and presence of suicidal ideations on Polish-language Twitter

    by Przemysław M. Waszak, Mateusz Otręba, Paweł Zagożdżon, Janusz Springer, Agnieszka Gmitrowicz


  • Open Access

    Effectiveness of antazoline versus amiodarone, flecainide, and propafenone in restoring sinus rhythm at the Emergency Department — case-match study

    by Janusz Springer, Michalina Pejska, Dariusz Kozłowski

    Atrial fibrillation (AF) is the most common arrhythmia among adults worldwide [1]. It is estimated that 19.2% of people ≥ 65 years of age in Poland have AF, most frequently paroxysmal [2].